<p>This is a summary of the European public assessment report (EPAR) for Verkazia. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use.</p><p>It is not intended to provide practical advice on how to use Verkazia.</p><p>For practical information about using Verkazia, patients should read the package leaflet or contact their doctor or pharmacist.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.</p></div>
Therapeutic Area (MeSH)
ATC Code
S01XA18
ATC Item
N/A
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ciclosporin | N/A | ciclosporin |
EMA Name
Verkazia
Medicine Name
Verkazia
Aliases
N/ANo risk management plan link.
